Analysis of Antibiotic Treatment and Microbiological Findings and Its Implication on Outcome in Patients with Parapneumonic Effusions

1 Tassi GF, Marchetti GP. Pleural disease: Historic perspective. In: Light RW, Lee YC, editors. Textbook of Pleural Diseases. 2^nd ed. London: Hodder; 2008. p. 1-9. Search in Google Scholar

2 Light RW. Parapneumonic effusions and empyema. Proc Am Thorac Soc. 2006;3(1):75-80. https://doi.org/10.1513/pats.200510-113JH PMid:16493154 Search in Google Scholar

3 Hasley PB, Albaum MN, Li YH, Fuhrman CR, Britton CA, Marrie TJ, et al. Do pulmonary radiographic findings at presentation predict mortality in patients with community-acquired pneumonia? Arch Intern Med. 1996;156(19):2206-12. PMid:8885819 Search in Google Scholar

4 Girdhar A., Shujaat A, Bajwa A. Management of infectious processes of the pleural space: A review. Pulm Med. 2012;2012:816502. https://doi.org/10.1155/2012/816502 PMid:22536502 Search in Google Scholar

5 Hooper JW, Larsen T, Custer DM, Schmaljohn CS. A lethal disease model for hantavirus pulmonary syndrome. Virology. 2001;289(1):6-14. https://doi.org/10.1006/viro.2001.1133 PMid:11601912 Search in Google Scholar

6 Chapman SJ, Davies RJ. The management of pleural space infection. Respitology. 2004;9(1):4-11. https://doi.org/10.1111/j.1440-1843.2003.00535.x PMid:14982595 Search in Google Scholar

7 Mc Cauley L, Dean N. Pneumonia and empyema: Causal, casual or unknown. J Thorac Dis. 2015;7(6):992-8. https://doi.org/10.3978/j.issn.2072-1439.2015.04.36 PMid:26150912 Search in Google Scholar

8 Finich S, Chalmers JD. Parapneumonic effusions: Epidemiology and predictors of pleural. Infection Curr Respir Care Rep. 2014;3:52-60. https://doi.org/10.1007/s13665-014-0074-4 Search in Google Scholar

9 Koegelenberg CF, Diacon AH, Bolliger CT. Parapneumonic pleural effusion and empyema. Respiration. 2008;75(3):241-50. https://doi.org/10.1159/000117172 PMid:18367849 Search in Google Scholar

10 Smith JA, Mulleroworth MH, Westlake GW, Tatoulis J. Empyema thoracis: 14-year experience in a teaching center. Ann Thorac Surg. 1991;51(1):39-42. https://doi.org/10.1016/0003-4975(91)90443-t PMid:1985571 Search in Google Scholar

11 Rodríguez Suárez P, Freixinet Gilart J, Hernández Pérez JM, Hussein Serhal M, López Artalejo A. Treatment of complicated parapneumonic pleural effusion and pleural parapneumonic empyema. Med Sci Monit. 2012;18(7):CR443-9. https://doi.org/10.12659/msm.883212 PMid:22739734 Search in Google Scholar

12 Colice GL, Curtis A, Deslauriers J, Heffner J, Light R, Littenberg B, et al. Medical and surgical treatment of parapneumonic effusions: An evidence-based guideline. Chest. 2000;118(4):1158-71. https://doi.org/10.1378/chest.118.4.1158 PMid:11035692 Search in Google Scholar

13 Heffner JE. Indications for draining a parapneumonic effusion: An evidence-based approach. Semin Respir Infect. 1999;14(1):48-58. PMid:10197397 Search in Google Scholar

14 Foley SP, Parrish JS. Pleural space infections. Life (Basel). 2023;13(2):376. https://doi.org/10.3390/life13020376 PMid:36836732 Search in Google Scholar

15 Bedawi EO, Ricciardi S, Hassan M, Gooseman MR, Asciak R, Castro-Anon O, et al. ERS/ESTS statement on the management of pleural infection in adults. Eur Respir J. 2022;61(2):2201062. https://doi.org/10.1183/13993003.01062-2022 PMid:36229045 Search in Google Scholar

16 Davies HE, Davies RJ, Davies CW, BTS Pleural Disease Guideline Group. Management of pleural infection in adults: British thoracic society pleural disease guideline 2010. Thorax. 2010;65(Suppl 2):ii41-53. https://doi.org/10.1136/thx.2010.137000. PMid:20696693 Search in Google Scholar

17 Shen KR, Bribriesco A, Crabtree T, Denlinger C, Eby J, Eiken P, et al. The American association for thoracic surgery consensus guidelines for the management of empyema. J Thorac Cardiovasc Surg. 2017;153(6):e129-46. https://doi.org/10.1016/j.jtcvs.2017.01.030 PMid:28274565 Search in Google Scholar

18 Metlay JP, Waterer GW, Long AC, Anzueto A, Brozek J, Crothers K, et al. Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American thoracic society and infectious diseases society of America. Am J Respir Crit Care Med. 2019;200(7):e45-67. https://doi.org/10.1164/rccm.201908-1581ST PMid:31573350 Search in Google Scholar

19 Maskell NA, Davies CW, Nunn AJ, Hedley EL, Gleeson FV, Miller R, et al. Controlled trial of intrapleural streptokinase for pleural infection. N Engl J Med. 2005;352(9):865-74. https://doi.org/10.1056/nejmoa042473. Erratum in: N Engl J Med. 2005;352(20):2146. PMid:15745977 Search in Google Scholar

20 Martin-Loeches I, Torres A, Nagavci B, Aliberti S, Antonelli M, Bassetti M, et al. ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia. Intensive Care Med. 2023;49(6):615-32. https://doi.org/10.1007/s00134-023-07033-8. Erratum in: Intensive Care Med. 2023;49(8):1040-1. https://doi.org/10.1007/s00134-023-07082-z PMid: 37012484 Search in Google Scholar

21 Djurić M, Djurić D, Ćulibrk T, Považan D. Parapneumonic effusions: Features, diagnostics and treatment options. Srp Arh Celok Lek. 2014;142(11-2):680-7. https://doi.org/10.2298/sarh1412680d PMid:25730997 Search in Google Scholar

22 Ozol D, Oktem S, Erdinc E. Complicated parapneumonic effusion and empyema thoracis: Microbiologic and therapeutic aspects. Respir Med. 2006;100(2):286-91. https://doi.org/10.1016/j.rmed.2005.05.018 PMid:15998584 Search in Google Scholar

23 Tsang KY, Leung WS, Chan VL, Lin AW, Chu CM. Complicated parapneumonic effusion and empyema thoracis: Microbiology and predictors of adverse outcomes. Hong Kong Med J. 2007;13(3):178-86. PMid:17548905 Search in Google Scholar

24 Chalmers JD, Singanayagam A, Murray MP, Scally C, Fawzi A, Hill AT. Risk factors for complicated parapneumonic effusion and empyema on presentation to hospital with community-acquired pneumonia. Thorax. 2009;64(7):592-7. https://doi.org/10.1136/thx.2008.105080 PMid:19131449 Search in Google Scholar

25 Gupta NM, Deshpande A, Rothberg MB. Pneumonia and alcohol use disorder: Implications for treatment. Cleve Clin J Med. 2020;87(8):493-500. https://doi.org/10.3949/ccjm.87a.19105. PMid:32737050. Search in Google Scholar

26 Sahn SA. Diagnosis and management of parapneumonic effusions and empyema. Clin Infect Dis. 2007;45(11):1480-6. https://doi.org/10.1086/522996 PMid:17990232 Search in Google Scholar

27 Corcoran JP, Wrightson JM, Belcher E, DeCamp MM, Feller-Kopman D, Rahman NM. Pleural infection: Past, present, and future directions. Lancet Respir Med. 2015;3(7):563-77. https://doi.org/10.1016/S2213-2600(15)00185-X PMid:26170076 Search in Google Scholar

28 Brims FJ, Lansley SM, Waterer GW, Lee YC. Empyema thoracis: New insights into an old disease. Eur Respir Rev. 2010;19(117):220-8. https://doi.org/10.1183/09059180.00005610 PMid:20956197 Search in Google Scholar

29 Vaziri M, Abed O. Management of thoracic empyema: Review of 112 cases. Acta Med Iran. 2012;50(3):203-7. PMid:22418990 Search in Google Scholar

30 Menzies SM, Rahman NM, Wrightson JM, Davies HE, Shorten R, Gillespie SH, et al. Blood culture bottle culture of pleural fluid in pleural infection. Thorax. 2011;66(8):658-62. https://doi.org/10.1136/thx.2010.157842 PMid:21459855 Search in Google Scholar

31 Sundaralingam A, Banka R, Rahman NM. Management of pleural infection. Pulm Ther. 2021;7(1):59-74. https://doi.org/10.1007/s41030-020-00140-7. PMid:33296057 Search in Google Scholar

32 Villena Garrido V, Ferrer Sancho J, Hernández Blasco L, De Pablo Gafas A, Pérez Rodríguez E, Rodríguez Panadero F, et al. Diagnóstico y tratamiento del derrame pleural [Diagnosis and treatment of pleural effusion]. Arch Bronconeumol. 2006;42(7):349-72. https://doi.org/10.1016/s1579-2129(06)60545-4 PMid:16945266 Search in Google Scholar

33 Hassan M, Cargill T, Harriss E, Asciak R, Mercer RM, Bedawi EO, et al. The microbiology of pleural infection in adults: A systematic review. Eur Respir J. 2019;54(3):1900542. https://doi.org/10.1183/13993003.00542-2019 PMid:31248959 Search in Google Scholar

34 Avner BS, Ginosyan A, Le J, Mak J, Qiryaqoz Z, Huffman C. Analysis of antibiotic use and clinical outcomes in adults with known and suspected pleural empyema. BMC Infect Dis. 2022;22(1):783. https://doi.org/10.1186/s12879-022-07759-8 PMid:36224539 Search in Google Scholar

35 Falguera M, Carratalà J, Bielsa S, García-Vidal C, Ruiz-González A, Chica I, et al. Predictive factors, microbiology and outcome of patients with parapneumonic effusion. Eur Respir J. 2011;38(5):1173-9. https://doi.org/10.1183/09031936.00000211 PMid:21565916 Search in Google Scholar

36 Lim TK. Management of parapneumonic pleural effusion. Curr Opin Pulm Med. 2001;7(4):193-7. https://doi.org/10.1097/00063198-200107000-00005 PMid:11470973 Search in Google Scholar

37 San José ME, Ferreiro L, Soneira ME, González-Barcala FJ, Vázquez MC, Golpe A, et al. Utility of measurement of interleukin-1ß and interleukin-8 in the diagnosis of complicated parapneumonic pleural effusions. Am J Clin Pathol. 2014;142(4):467-73. https://doi.org/10.1309/AJCPDC7PS8TIPBXP PMid:25239413 Search in Google Scholar

38 Light RW, Rodriguez RM. Management of parapneumonic effusions. Clin Chest Med. 1998;19(2):373-82. https://doi.org/10.1016/s0272-5231(05)70084-8 PMid:9646988 Search in Google Scholar